Luca Emili

Luca Emili is a seasoned serial entrepreneur with a strong background in cybersecurity and IT-cloud sectors who transitioned into the healthcare industry by purchasing a digital Contract Research Organization (CRO).

Recognizing the challenges in pharma and Medtech industries, Luca founded InSilicoTrials Technologies with a mission to digitalize R&D processes, enhance the delivery of safer cures efficiently, and reduce costs.

With a focus on building partnerships and leading initiatives like the Good Simulation Practice for healthcare at the Avicenna Alliance, Luca aims to revolutionize the healthcare sector using digital solutions.

Believing in the transformative power of digitalization in healthcare R&D, Luca assembled a diverse team with expertise in computational science, drugs development, regulatory approval, and IT to streamline R&D processes and regulatory approvals.

InSilicoTrials Technology offers a user-friendly web-based platform that simplifies the use of vast knowledge from research institutions worldwide, enabling easy access for scientists, researchers, and doctors.

Luca collaborates with innovative CROs, Pharma, and MedTech companies to optimize their R&D efforts by incorporating in Silico components and providing digital tools and expertise.

As CEO of InSilicoTrials, Luca is at the forefront of developing groundbreaking approaches to modeling and simulation that aim to de-risk and accelerate the approval of medicines and medical devices, paving the way for enhanced patient care.

With a strong educational background in computer sciences and economics, Luca Emili brings a unique blend of expertise and experience to drive innovation in the healthcare industry.